Literature DB >> 1675788

Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.

A A Neyfakh1, V E Bidnenko, L B Chen.   

Abstract

Bacillus subtilis cells selected for their resistance to rhodamine 6G demonstrated a multidrug-resistance (MDR) phenotype resembling that of mammalian MDR cells. Like MDR in mammalian cells, MDR in bacteria was mediated by the efflux of the drugs from the cells. The bacterial multidrug efflux system transported similar drugs and was sensitive to similar inhibitors as the mammalian multidrug transporter, P-glycoprotein. The gene coding for the bacterial multidrug transporter, like the P-glycoprotein gene in mammalian MDR cells, was amplified in the resistant bacteria. On the other hand, the bacterial multidrug transporter showed no sequence similarity to P-glycoprotein but exhibited an obvious homology to tetracycline efflux pumps and carbohydrate-ion symporters. These results show that the transport of structurally unrelated molecules can be mediated by members of different families of membrane transporters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675788      PMCID: PMC51750          DOI: 10.1073/pnas.88.11.4781

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  REQUIREMENTS FOR TRANSFORMATION IN BACILLUS SUBTILIS.

Authors:  C Anagnostopoulos; J Spizizen
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

Review 2.  The biochemistry of P-glycoprotein-mediated multidrug resistance.

Authors:  J A Endicott; V Ling
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

3.  Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.

Authors:  K Yusa; T Tsuruo
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

Review 4.  P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.

Authors:  P F Juranka; R L Zastawny; V Ling
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.191

5.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

6.  Stable gene amplification in the chromosome of Bacillus subtilis.

Authors:  L Jannière; B Niaudet; E Pierre; S D Ehrlich
Journal:  Gene       Date:  1985       Impact factor: 3.688

7.  Chromosomal insertions of Tn917 in Bacillus subtilis.

Authors:  M A Vandeyar; S A Zahler
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

8.  The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein.

Authors:  J P McGrath; A Varshavsky
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

9.  Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus.

Authors:  J M Tennent; B R Lyon; M Midgley; I G Jones; A S Purewal; R A Skurray
Journal:  J Gen Microbiol       Date:  1989-01

10.  Chromosomal-DNA amplification in Bacillus subtilis.

Authors:  C R Wilson; A E Morgan
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

View more
  107 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Development, validation, and application of PCR primers for detection of tetracycline efflux genes of gram-negative bacteria.

Authors:  R I Aminov; J C Chee-Sanford; N Garrigues; B Teferedegne; I J Krapac; B A White; R I Mackie
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

Review 3.  Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrA.

Authors:  Jose Antonio Escudero; Alvaro San Millan; Belen Gutierrez; Laura Hidalgo; Roberto M La Ragione; Manal AbuOun; Marc Galimand; María José Ferrándiz; Lucas Domínguez; Adela G de la Campa; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

5.  Bacillus subtilis LmrA is a repressor of the lmrAB and yxaGH operons: identification of its binding site and functional analysis of lmrB and yxaGH.

Authors:  Ken-Ichi Yoshida; Yo-Hei Ohki; Makiko Murata; Masaki Kinehara; Hiroshi Matsuoka; Takenori Satomura; Reiko Ohki; Miyuki Kumano; Kunio Yamane; Yasutaro Fujita
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

Review 6.  Active efflux mechanisms for antimicrobial resistance.

Authors:  S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

7.  The MAR1 transporter is an opportunistic entry point for antibiotics.

Authors:  Sarah S Conte; Alan M Lloyd
Journal:  Plant Signal Behav       Date:  2010-01

8.  Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis.

Authors:  H Bolhuis; D Molenaar; G Poelarends; H W van Veen; B Poolman; A J Driessen; W N Konings
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

9.  The 3' conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants.

Authors:  I T Paulsen; T G Littlejohn; P Rådström; L Sundström; O Sköld; G Swedberg; R A Skurray
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Molecular characterization of the staphylococcal multidrug resistance export protein QacC.

Authors:  I T Paulsen; M H Brown; S J Dunstan; R A Skurray
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.